605 A Phase 1, Open-label, Dose-escalation Study of Oral Administration of the Investigational Agent MLN0128 in Combination with Paclitaxel (P) in Patients (pts) with Advanced Solid Malignancies
Saved in:
| Title: | 605 A Phase 1, Open-label, Dose-escalation Study of Oral Administration of the Investigational Agent MLN0128 in Combination with Paclitaxel (P) in Patients (pts) with Advanced Solid Malignancies |
|---|---|
| Authors: | Burris, H., Hart, L., Kurkjian, C., Berk, G., Lipman, P., Patel, C., Rommel, C., Martin, M., Infante, J. |
| Source: | European Journal of Cancer. Nov2012 Supplement, Vol. 48, p186-186. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09598049 |
|---|---|
| DOI: | 10.1016/S0959-8049(12)72402-4 |
